A traditional Chinese medicine for adjuvant treatment of ascites of middle and advanced liver cancer

Abstract

The invention relates to the field of traditional Chinese medicine, and more specifically relates to traditional Chinese medicine for treating hepatoma ascites in the middle and late period. The traditional Chinese medicine comprises the following components in parts by weight: 5 to 50 parts of radix bupleuri, 5 to 50 parts of mangnolia officinalis, 5 to 50 parts of immature bitter orange, 5 to 50parts of the root of three-nerved spicebush, 5 to 50 parts of radix aucklandiae, 5 to 50 parts of fructus amomi, 5 to 50 parts of rhizoma atractylodis, 5 to 50 parts of chicken's gizzard-membrane, 5to 50 parts of dried tangerine or orange peel, 5 to 50 parts of pericarpium citri reticulatae viride, 5 to 50 parts of ginger processed pinellia, 5 to 50 parts of rhizoma sparganii, 5 to 50 parts of curcuma zedoary, 5 to 50 parts of poria cocos, 5 to 50 parts of grifola, 5 to 50 parts of rhizoma alismatis, 5 to 50 parts of pericarpium arecae, 5 to 50 parts of herba lycopi, 5 to 50 parts of turtleshell, 5 to 50 parts of raw oyster shell, 5 to 50 parts of cooked rhubarb, 5 to 50 parts of pokeberry root, 5 to 50 parts of semen cassiae, 5 to 50 parts of Chinese actinidia root, 5 to 50 parts of coptis chinensis, 5 to 50 parts of raw liquorice, 5 to 50 parts of codonopsis pilosula, 5 to 50 parts of astragalus membranaceus, 5 to 50 parts of white atractylodes rhizome, 5 to 50 parts of Chinese yam, 5 to 50 parts of Chinese angelica, 5 to 50 parts of the fruit of Chinese wolfberry and 5 to 50 parts of radix paeoniae alba.

Description

Technical field: [0001] The invention relates to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine for treating ascites of middle and advanced liver cancer. Background technique: [0002] Primary liver cancer is one of the most common malignant tumors in my country, and its mortality rate is very high, ranking second in my country's urban and rural malignant tumors. The incidence of liver cancer in my country accounts for 45% of the world's total. Late refractory ascites is the main complication of advanced liver cancer. If it cannot be effectively treated and controlled, it will seriously affect the quality of life of patients. The condition is dangerous and the prognosis is extremely poor. Western medicine mainly adopts diuresis, salt restriction, peritoneal puncture to aspirate fluid, and intraperitoneal injection of chemotherapeutic drugs and biological response modifiers after ascites aspiration to control the rapid and massive ...

AI Technical Summary

Problems solved by technology

[0005] The present invention aims at the above problems and provides a traditional Chinese medicine for the treatment of mid-advanced liver cancer ascites, which solves the difficulties in preventing and treating mid-late liver cancer ascites in the prior art.